Status:

COMPLETED

Optimizing Exposure Therapy for Anxiety Disorders

Lead Sponsor:

University of California, Los Angeles

Conditions:

Social Anxiety Disorder

Panic Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.

Detailed Description

A substantial number of individuals fail to achieve clinically significant symptom relief from exposure-based therapies or experience a return of fear following exposure therapy completion. The prevai...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Seeking treatment for social anxiety or panic disorder and demonstration of elevated scores using standardized self-report measures and diagnostic interview
  • Age 18 to 65
  • Either stabilized on psychotropic medications or medication-free
  • English-speaking
  • Access to telehealth resources (for Zoom treatment sessions after March 2020 due to COVID-19)
  • Exclusion criteria include:
  • Patient report of serious medical conditions - such as respiratory (e.g., chronic obstructive pulmonary disease), cardiovascular, pulmonary, neurological, muscular-skeletal diseases - or pregnancy
  • Active suicidal ideation or self-harm in the past year; history of suicide attempts in the last 10 years
  • History of bipolar disorder, psychosis, mental retardation or organic brain damage
  • Substance abuse/dependence within last 6 months
  • Concurrent therapy focused on anxiety. Participants are allowed to be in other forms of therapy, provided the therapy does not focus on anxiety (e.g., supportive counseling) and they have been stabilized on this alternative therapy for at least 6 months

Exclusion

    Key Trial Info

    Start Date :

    August 14 2015

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2025

    Estimated Enrollment :

    89 Patients enrolled

    Trial Details

    Trial ID

    NCT04048824

    Start Date

    August 14 2015

    End Date

    January 1 2025

    Last Update

    April 6 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of California, Los Angeles

    Los Angeles, California, United States, 90095